SCHEMBL6236301

SCHEMBL6236301

CCCC(=O)CC(=O)O.CCOC(=O)c1nc2c(nc1C)CCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 6/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 1/20 0.38
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 6/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
KMT2A Q03164 2/20 0.37
PPARG P37231 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
MAPT P10636 3/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
PARP1 P09874 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.34
CACNB4 O00305 1/20 0.34
CACNA1A O00555 1/20 0.34
CACNA1G O43497 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5880357 0.85 KDM4E (0.48) ACHECYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL6236293 0.76 CYP1A2 (0.39) ACHECYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL26617701 0.72 KDM4E (0.47) ACHECYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL30681964 0.72 KDM4E (0.47) ACHECYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL26617997 0.71 KDM4E (0.46) ACHECYP1A2KDM4EALDH1A1SMN1; SMN2
SCHEMBL31345638 0.71 KDM4E (0.46) ACHECYP1A2KDM4EALDH1A1SMN1; SMN2
SCHEMBL9014873 0.70 KDM4E (0.45) ACHECYP1A2KDM4EALDH1A1SMN1; SMN2
SCHEMBL21572852 0.69 ALDH1A1 (0.56) CYP1A2KDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL2410364 0.69 KDM4E (0.41) ACHECYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL2408933 0.69 KDM4E (0.41) ACHECYP1A2CYP2C9KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1587796-A1 SATURATED QUINOXALINE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR LIGANDS AstraZeneca AB (SE) 2005-10-26 EP disclosed
WO-2004069813-A1 SATURATED QUINOXALINE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2004-08-19 WO disclosed